Benkő, B.-M.; Szabó, B.-I.; Kádár, S.; Szabó, E.; Tóth, G.; Szente, L.; Tonka-Nagy, P.; Zelkó, R.; Sebe, I.
Development of Low-Dose Disulfiram Rectal Suppository Intended for Application in Post-Treatment Lyme Disease Syndrome. Pharmaceutics 2025, 17, 849.
https://doi.org/10.3390/pharmaceutics17070849
AMA Style
Benkő B-M, Szabó B-I, Kádár S, Szabó E, Tóth G, Szente L, Tonka-Nagy P, Zelkó R, Sebe I.
Development of Low-Dose Disulfiram Rectal Suppository Intended for Application in Post-Treatment Lyme Disease Syndrome. Pharmaceutics. 2025; 17(7):849.
https://doi.org/10.3390/pharmaceutics17070849
Chicago/Turabian Style
Benkő, Beáta-Mária, Bálint-Imre Szabó, Szabina Kádár, Edina Szabó, Gergő Tóth, Lajos Szente, Péter Tonka-Nagy, Romána Zelkó, and István Sebe.
2025. "Development of Low-Dose Disulfiram Rectal Suppository Intended for Application in Post-Treatment Lyme Disease Syndrome" Pharmaceutics 17, no. 7: 849.
https://doi.org/10.3390/pharmaceutics17070849
APA Style
Benkő, B.-M., Szabó, B.-I., Kádár, S., Szabó, E., Tóth, G., Szente, L., Tonka-Nagy, P., Zelkó, R., & Sebe, I.
(2025). Development of Low-Dose Disulfiram Rectal Suppository Intended for Application in Post-Treatment Lyme Disease Syndrome. Pharmaceutics, 17(7), 849.
https://doi.org/10.3390/pharmaceutics17070849
